Lorazepam-<sup>13</sup>C<sub>2</sub>-d<sub>4</sub> (CRM)

Lorazepam-13C2-d4 (CRM)

CAT N°: 18731

Lorazepam-13C2-d4 (CRM) (Item No. 18731) is a certified reference material intended for use as an internal standard for the quantification of lorazepam (Item Nos. ISO60202 | 15891) by GC- or LC-MS. Lorazepam is categorized as a benzodiazepine that has anxiolytic properties.{42975,23626} It is a metabolite of diclazepam (Item Nos. 28623 | 15554).{25722} Lorazepam-13C2-d4 is regulated as a Schedule IV compound in the United States. Lorazepam-13C2-d4 (CRM) (Item No. 18731) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Reference Materials RMs and Certified Reference Materials CRMs are dispatched directly to the end-user in accordance with ISO requirements. Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • 7-chloro-5-(2-chlorophenyl-d4)-3-hydroxy-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one-2,3-13C2
  • Correlated keywords
    • deuterated deuterium Apo ApoLorazepam NSC-279758 NSC279758 Wy-4036 Wy4036 13-C
  • Product Overview:
    Lorazepam-13C2-d4 (CRM) (Item No. 18731) is a certified reference material intended for use as an internal standard for the quantification of lorazepam (Item Nos. ISO60202 | 15891) by GC- or LC-MS. Lorazepam is categorized as a benzodiazepine that has anxiolytic properties.{42975,23626} It is a metabolite of diclazepam (Item Nos. 28623 | 15554).{25722} Lorazepam-13C2-d4 is regulated as a Schedule IV compound in the United States. Lorazepam-13C2-d4 (CRM) (Item No. 18731) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

We also advise you